Arteriovenous malformations of the brain: outcome of conventional radiotherapy in the management of 33 cases.
Thirty three patients with inoperable arteriovenous malformations of the brain received conventionally fractionated megavoltage photon radiotherapy. The dose varied between 30.00 wand 50.00 Gy with a median of 40.00 Gy. Treatment was not associated with any significant morbidity. Follow-up ranged from 16 months to 148 months, with a median of 79 months. The projected 5-year survival is 92% and rebleed-free survival 78%. There was a trend of increased bleed-free survival for doses greater than 46.00 Gy.
Spry
N A
NA
Department of Oncology, Wellington Hospital, New Zealand.
Lamb
D S
DS
Millar
J L
JL
Balakrishnan
V
V
Symons
L A
LA
D000293:Adolescent; D000328:Adult; D002543:Cerebral Hemorrhage / Q000517:prevention & control; D002648:Child; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D002538:Intracranial Arteriovenous Malformations / Q000175:diagnosis / Q000401:mortality / Q000532:radiotherapy*; D008297:Male; D008875:Middle Aged; D011879:Radiotherapy Dosage